1. Degenhardt L, Stockings E, Patton G, Hall WD, Lynskey M. The increasing global health priority of substance use in young people. Lancet Psychiatry 2016; 3: 251-264.
2.
Prevention, treatment and care of substance use disorders among adolescents. Statement by the UNODC‐WHO Informal Scientific Network, 2024 – Volkow – 2024 – World Psychiatry – Wiley Online Library. Available at: https://onlinelibrary.wiley.com/doi/full/10.1002/wps.21260 (Accessed: 13.05.2025).
3.
European Monitoring Centre for Drugs and Drug Addiction. ESPAD report 2019: results from the European school survey project on alcohol and other drugs. LU: Publications Office; 2020. Available at: https://data.europa.eu/doi/10.2810/877033 (Accessed: 13.05.2025).
4.
European Monitoring Centre for Drugs and Drug Addiction. Institute of Public Health (Albania). Albania: National Drug Report 2017. LU: Publications Office; 2017. Available at: https://data.europa.eu/doi/10.2810/08738 (Accessed: 13.05.2025).
5.
Tahiraj E, Cubela M, Ostojic L, Rodek J, Zenic N, Sekulic D, Lesnik B. Prevalence and factors associated with substance use and misuse among Kosovar adolescents; cross sectional study of scholastic, familial-, and sports-related factors of influence. Int J Environ Res Public Health 2016; 13: 502. DOI: 10.3390/ijerph13050502.
6.
Health Behaviour in School-aged Children (HBSC) study. Available at: https://www.who.int/europe/initiatives/health-behaviour-in-school-aged-children-(hbsc)-study (Accessed: 13.05.2025).
7.
Consequences of youth substance abuse. Available at: https://ojjdp.ojp.gov/sites/g/files/xyckuh176/files/pubs/drugid/ration-03.html (Accessed: 13.05.2025).
8.
Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, et al. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiatry 2019; 76: 426-434.
9.
Robinson T, Ali MU, Easterbrook B, Hall W, Jutras-Aswad D, Fischer B. Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: a systematic review and meta-analysis. Psychol Med 2023; 53: 3858-3868.
10.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
11.
Beck AT, Steer RA, Brown G. Beck Depression Inventory-II (BDI-II). APA PsycTests. DOI: https://doi.org/10.1037/t00742-000.
12.
Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744.
13.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
14.
Guze SB. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). Am J Psychiatry 1995; 152: 1228-1228.
15.
Free Online Spreadsheet Software: Excel | Microsoft 365. Available at: https://www.microsoft.com/en-us/microsoft-365/excel (Accessed: 14.05.2025).
16.
Drogat | Instituti i Shëndetit Publik. Available at: https://www.ishp.gov.al/departamenti-i-epidemiologjise-dhe-sistemeve-shendetesore/drogat/ (Accessed: 14.05.2025).
17.
ESPAD Report 2019 | www.espad.org. Available at: https://www.espad.org/espad-report-2019 (Accessed: 14.05.2025).
18.
Teenage Drug Use Statistics (2023): Data & Trends on Abuse. NCDAS. Available at: https://drugabusestatistics.org/teen-drug-use/ (Accessed: 13.05.2025).
19.
World Drug Report 2023. United Nations: Office on Drugs and Crime. Available at: www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2023.html (Accessed: 13.05.2025).
20.
Farley JP, Kim-Spoon J. Longitudinal associations among impulsivity, friend substance use, and adolescent substance use. J Addict Res Ther 2015; 6: 1000220. DOI: 10.4172/2155-6105.1000220.
21.
Durmishi L, Filipova M, Durmishi A, Ibrahimi S. Managing a positive and life-skills development in the school-based curricula: a literature review on the sustainable education. Educational and Scientific Policy Strategies 2024; 32: 531-546.
22.
Myhr A, Vesterbekkmo RK, Samarawickrema I, Sund ER. Trends in Norwegian adolescents’ substance use between 2014 and 2022: socioeconomic and gender differences. BMC Public Health 2024; 24: 2482. DOI: 10.1186/s12889-024-19983-9.
23.
Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am 2010; 33: 339-355.
24.
Van Etten ML, Anthony JC. Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin. Drug Alcohol Depend 1999; 54: 117-125.
25.
Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142: 1259-1264.
26.
Botvin GJ, Griffin KW. Life skills training: preventing substance misuse by enhancing individual and social competence. New Dir Youth Dev 2014; 2014: 57-65.
27.
Liddle HA, Dakof GA, Rowe CL, Henderson C, Greenbaum P, Wang W, Alberga L. Multidimensional Family Therapy as a community-based alternative to residential treatment for adolescents with substance use and co-occurring mental health disorders. J Subst Abuse Treat 2018; 90: 47-56.
28.
van der Pol TM, Hoeve M, Noom MJ, Stams GJJM, Doreleijers TAH, van Domburgh L, Vermeiren RRJM. Research review: The effectiveness of multidimensional family therapy in treating adolescents with multiple behavior problems – a meta-analysis. J Child Psychol Psychiatry 2017; 58: 532-545.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). License allowing third parties to download and share its works but not commercially purposes or to create derivative works.